Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Steven E. Kahn's publication output changed over time?
ScholarIQpublication output · 1993–2023
Output grew0% over the shown period — from 1 works in 1993 to 1 in 2023.
1
2
1
2
1
1
1
1
1
1
1993200320042006201020132018201920212023
What are the most-cited papers on Steven E. Kahn?
ScholarIQmost cited works
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Steven E. Kahn, Rebecca L. Hull, Kristina M. Utzschneider
Nature. 20065,466 Citations
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
Steven E. Kahn, Steven M. Haffner, Mark Heise, William H. Herman, Rury R. Holman, Nigel C. Jones, Barbara G. Kravitz, John M. Lachin, Mark O’Neill, Bernard Zinman, Giancarlo Viberti
New England Journal of Medicine. 20062,958 Citations
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
A. Michael Lincoff, Kirstine Brown‐Frandsen, Helen M. Colhoun, John Deanfield, Scott S. Emerson, Sille Esbjerg, Søren Hardt‐Lindberg, G. Kees Hovingh, Steven E. Kahn, Robert F. Kushner, Ildiko Lingvay, Tuğçe Kalaycı Oral, Marie Mide Michelsen, Jorge Plutzky, Christoffer W. Tornøe, Donna H. Ryan
New England Journal of Medicine. 20232,815 CitationsOPEN ACCESS
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes
Steven E. Kahn
Diabetologia. 20032,161 CitationsOPEN ACCESS
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Steven E. Kahn, Mark E. Cooper, Stefano Del Prato
The Lancet. 20131,759 Citations
Related on ScholarIQ
University of Washington
Institution
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Paper
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
Paper
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
Paper
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes
Paper
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Paper